Yi Lv

803 total citations
31 papers, 581 citations indexed

About

Yi Lv is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Yi Lv has authored 31 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Yi Lv's work include Liver Disease Diagnosis and Treatment (6 papers), Alcohol Consumption and Health Effects (6 papers) and Liver physiology and pathology (4 papers). Yi Lv is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Alcohol Consumption and Health Effects (6 papers) and Liver physiology and pathology (4 papers). Yi Lv collaborates with scholars based in China, Hong Kong and Japan. Yi Lv's co-authors include Jia Xiao, Kwok‐Fai So, Feiyue Xing, Yingxia Liu, George L. Tipoe, Nai-Kei Wong, Xiaogang Wang, Hao Gao, Jing Liu and Kazuo Koike and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Yi Lv

30 papers receiving 570 citations

Peers

Yi Lv
Shu Dai China
Neeraj Kapur United States
Min-Jae Lee South Korea
S. Choudhary United States
Yi Lv
Citations per year, relative to Yi Lv Yi Lv (= 1×) peers Yifen Wang

Countries citing papers authored by Yi Lv

Since Specialization
Citations

This map shows the geographic impact of Yi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lv more than expected).

Fields of papers citing papers by Yi Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lv. The network helps show where Yi Lv may publish in the future.

Co-authorship network of co-authors of Yi Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Lv. A scholar is included among the top collaborators of Yi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Lv. Yi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Zelin, Bai Sun, Kaikai Gao, et al.. (2024). A reversible implantable memristor for health monitoring applications. Materials Today Bio. 26. 101096–101096. 12 indexed citations
2.
Chen, Feng, Zhaodi Che, Yingxia Liu, et al.. (2023). Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model. Gastroenterology report. 12. goae016–goae016. 1 indexed citations
3.
Liu, Peng, et al.. (2023). Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis. Frontiers in Immunology. 13. 1096402–1096402. 21 indexed citations
4.
Zhang, Nana, Huimin Yao, Zhixuan Zhang, et al.. (2023). Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment. Frontiers in Immunology. 14. 1131588–1131588. 10 indexed citations
5.
Lv, Yi & Feiyue Xing. (2022). Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation.. PubMed. 46(2). 186–194. 1 indexed citations
6.
Chen, Guangya, Yi Lv, Wei Ni, et al.. (2020). Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. Canadian Journal of Gastroenterology and Hepatology. 2020. 1–7. 16 indexed citations
7.
Lv, Yi, Kwok‐Fai So, & Jia Xiao. (2020). Liver regeneration and alcoholic liver disease. Annals of Translational Medicine. 8(8). 567–567. 20 indexed citations
8.
Luo, Pingping, Fei Wang, Nai-Kei Wong, et al.. (2019). Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCG. Cellular and Molecular Gastroenterology and Hepatology. 9(1). 145–160. 30 indexed citations
9.
Lv, Yi, Kwok‐Fai So, Nai-Kei Wong, & Jia Xiao. (2019). Anti-cancer activities of S-allylmercaptocysteine from aged garlic. Chinese Journal of Natural Medicines. 17(1). 43–49. 32 indexed citations
10.
Sun, Xiaoming, Yi Lv, Lu Huang, et al.. (2019). Pro-inflammatory cytokines serve as communicating molecules between the liver and brain for hepatic encephalopathy pathogenesis and Lycium barbarum polysaccharides protection. Journal of Ethnopharmacology. 248. 112357–112357. 25 indexed citations
11.
Lv, Yi, Feng Chen, Xiaoyan Wang, et al.. (2018). Co-stimulation of LPAR1 and S1PR1/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases. Stem Cell Research & Therapy. 9(1). 161–161. 10 indexed citations
12.
Fu, Haifeng, et al.. (2018). ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth. Tissue and Cell. 54. 65–71. 4 indexed citations
13.
Xiao, Jia, Feiyue Xing, Yingxia Liu, et al.. (2017). Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway. Acta Pharmaceutica Sinica B. 8(4). 575–586. 47 indexed citations
14.
Lv, Yi, Jia Xiao, Jing Liu, & Feiyue Xing. (2017). E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma. Journal of Cancer. 8(7). 1205–1213. 36 indexed citations
15.
Xiao, Jia, Yi Lv, Fujun Jin, et al.. (2017). LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 43(5). 1926–1938. 84 indexed citations
16.
Li, Jingjing, et al.. (2017). Zeaxanthin dipalmitate alleviates hepatic injury induced by superimposed chronic hepatitis B and non-alcoholic steatohepatitis in non-obese mice. Journal of Asian Natural Products Research. 19(9). 910–923. 11 indexed citations
17.
Ruan, Zhiping, Rui Xu, Yi Lv, et al.. (2012). PTEN Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(2). 113–121. 18 indexed citations
19.
Liu, Qingyang, Aiguo Cheng, Fang Qiu, et al.. (2006). [Influence of the escharectomy during stock stage on the peripheral lymphocyte apoptosis and the antigen presentation function of monocytes in peripheral blood of scalded rats].. PubMed. 22(6). 415–8. 1 indexed citations
20.
Lv, Yi. (2005). TREATMENT OF SEVERE ACUTE PANCREATITIS WITH LARGE DOSAGE OF DEXAMETHSONE IN THE EARLIER TIME.. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026